Covid-19 In Patients With Inflammatory Arthritis: A Prospective Study On The Effects Of Comorbidities And Dmards On Clinical Outcomes

Rebecca H Haberman,Rochelle Castillo,Alan Chen,Di Yan,Deborah Ramirez, Vaish Sekar,Robert Lesser,Gary Solomon, Andrea L Niemann,Rebecca B Blank,Peter Izmirly,Dan E Webster,Alexis Ogdie,Andrea B Troxel,Samrachana Adhikari,Jose U Scher

ARTHRITIS & RHEUMATOLOGY（2020）

引用 87|浏览13

暂无评分

摘要

In patients with underlying IA, COVID-19 outcomes were worse in those receiving glucocorticoids but not in patients on maintenance anti-cytokine therapy. Further work is needed to understand whether immunomodulatory therapies affect COVID-19 incidence.

查看译文

关键词

COVID-19,JAKi,biologics,csDMARDs,psoriatic arthritis,rheumatoid arthritis,spondyloarthritis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要